Apollomics, Inc.

NASDAQ:APLM

Biotechnology

Healthcare
$17.84 +34.72%

+$6.03 today

Market cap
$52.00M
Beta
1.45
P/E (TTM)
-3.1
EPS (TTM)
-$25.98
52W Low $3.66High $42.12

Volume 0.02M

Average 0.02M

APLM Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Apollomics, Inc.NASDAQ: APLM

Accumulated OCI · Q4 FY2025 · quarter ended Dec 2025

Accumulated OCI broadly unchanged from a year ago

Accumulated OCI stood at $3.44M at the end of Q4 FY2025, up 0.0% from a year earlier. Over 3 fiscal years it compounded at +0.4% a year.

Context

  • Accumulated OCI amounted to 51.2% of total assets at the end of Q4 FY2025, up 24.9 pp from a year earlier.
  • Accumulated OCI increased in 1 of the last 3 fiscal years.

What to watch

Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$3.44M— QoQ
Last fiscal yearDec 2025
$3.44M+0.0% YoY
Year agoDec 2024
$3.44M+0.0% since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.0%——
1 year+0.0%——
3-year CAGR+0.4%——
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
3.44M USD
Year-over-year change
+0.0%
4-year CAGR
-27.3%

Accumulated OCI vs competitors

How APLM compares with its peers on the latest reported figures

  • APLM's Dec 2025 Accumulated OCI of $3.44M is the highest of the 2 companies compared; the peer median is -$4.35M.
  • Its year-over-year change of +0.0% is the lowest of 2, against a peer median of +4.2%.
  • Accumulated OCI amounts to 51.2% of total assets for APLM, versus a peer median of 12.6%.
APLM Competitors Peer median
Accumulated OCI for APLM and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
APLMApollomics, Inc.Dec 2025$3.44M +0.0%+0.4%51.2%
ANLAdlai Nortye Ltd.Dec 2025-$4.35M +4.2%+21.9%12.6%
Peer median (excluding APLM) -$4.35M+4.2%+21.9%12.6%

Competitors are the stored peer set for APLM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents46.74M32.68M32.06M9.77M3.28M
Short-term Investments47.74M21.94M5.76M00
Net Receivables506K547K466K127K2.49M
Inventory2.26M0000
Other Current Assets120K07K00
Total Current Assets99.37M55.79M39.93M10.27M6.05M
Property, Plant & Equipment (Net)1.32M1.48M586K1.02M580K
Goodwill00000
Intangible Assets14.8M14.78M14.76M1.74M0
Long-term Investments7.84M4.31M000
Tax Assets00000
Other Non-current Assets113K124K119K75K83K
Total Non-current Assets24.07M20.69M15.46M2.83M663K
Total Assets123.44M76.48M55.39M13.1M6.71M
Account Payables00000
Short-term Debt2.16M04.24M00
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities(508K)68K000
Total Current Liabilities13.56M12.36M13.56M7.4M6.33M
Long-term Debt322.22M0000
Deferred Tax Liabilities(3.62M)0000
Deferred Revenue (Non-current)3.62M0000
Other Non-current Liabilities322.22M511.86M330K102K3.14M
Total Non-current Liabilities322.74M512.24M597K835K3.58M
Total Liabilities336.3M524.6M14.15M8.23M9.9M
Common Stock40K41K9K11K21K
Retained Earnings(235.44M)(474.6M)(646.97M)(700.82M)(711.76M)
Accumulated OCI12.29M3.4M26.72M3.44M3.44M
Other Stockholders Equity010.83M035.71M34.73M
Minority Interest00000
Total Equity(212.86M)(448.12M)41.23M4.86M(3.19M)
Total Debt325.41M991K4.66M966K643K
Net Debt278.67M(31.68M)(27.4M)(8.8M)(2.63M)

Apollomics, Inc.

NASDAQ:APLM

Intrinsic Alpha fair value

Locked

Current Price

$17.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.